Seeking Alpha

ImClone Systems Inc. (IMCL)

()

News & PR
Market Currents

Buzz
Twitter: IMCL

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

Dividend Aristocrats: 3 to Watch

Oct 20 • Avi Morris • 13 Comments
VC Financings Boost Interest in Biotech

Jul 24 • The Burrill Report • Comment!
A Look at D.E. Shaw's Q408 Holdings: Just for Fun

Apr 22 • Market Folly • 2 Comments
Moore Capital Investments: Theme Is Economic Recovery

Mar 18 • Market Folly • 4 Comments
Carl Icahn's Top Three Stock Ideas

Mar 5 • The Manual of Ideas • 2 Comments
A Comparison of M&A Activity During Bull and Bear markets

Jan 30 • Dr. Kris • 2 Comments
Hedge Fund Portfolio Tracking: D.E. Shaw & Co (David E. Shaw), Q3 2008

Jan 16 • Market Folly • 1 Comment
Hedge Fund Portfolio Tracking: SAC Capital (Steven Cohen), Q3 2008

Jan 15 • Market Folly • Comment!
2009: Positive Outlook for Biotech

Jan 8 • Michael Becker • 1 Comment
Hedge Fund Tracking: Farallon Capital Management (Thomas Steyer), Q3 2008

Jan 6 • Market Folly • 2 Comments
Hedge Fund Tracking: Moore Capital Management (Louis Bacon), Q3 2008

Dec 10, 2008 • Market Folly • 7 Comments
Biotech ETFs a Rare Safe Haven

Nov 14, 2008 • Tom Lydon • Comment!
Pension Fund Thinks Lilly / Imclone Deal Too Cheap

Oct 31, 2008 • Derek Lowe • 1 Comment
Even Fatter Yields for Pfizer; M&A Targets in the Sector

Oct 17, 2008 • Mike Havrilla • 3 Comments
Four Thoughts on the Imclone/Lilly Deal

Oct 7, 2008 • Derek Lowe • Comment!
A Biotech Bonanza for ImClone and Dendreon

Oct 7, 2008 • Mike Huckman • 1 Comment
Discovery Labs: The Next Biotech Buy?

Oct 6, 2008 • Mike Havrilla • Comment!
Wall Street Breakfast: Must-Know News

Oct 6, 2008 • SA Editor Eli Hoffmann • 10 Comments
Is Eli Lilly ImClone's Secret Bidder?

Oct 3, 2008 • Mike Huckman • 1 Comment
Would a Lilly/Imclone Deal Make Sense?

Oct 2, 2008 • Derek Lowe • 2 Comments
Bail-out Buys - Fast Money Recap (10/1/08)

Oct 1, 2008 • SA Editor Joan Wickham • 2 Comments
Pfizer Cuts Back - But Is It Slimming Down for ImClone?

Sep 30, 2008 • Derek Lowe • 2 Comments
Eli Lilly, ImClone: The Waiting Game Continues

Sep 29, 2008 • Mike Huckman • 2 Comments
ImClone to Reveal Mystery Suitor?

Sep 29, 2008 • Eben Tessari • Comment!
Wall Street Breakfast: Must-Know News

Sep 29, 2008 • SA Editor Eli Hoffmann • 22 Comments
Predictions on Imclone's Suitors

Sep 28, 2008 • Derek Lowe • 3 Comments
FDA Decision Calendar: Some Potentially Prominent Decisions in Early 2009

Sep 24, 2008 • Mike Havrilla • Comment!
Wall Street Breakfast: Must-Know News

Sep 24, 2008 • SA Editor Rachael Granby • 35 Comments
Has Urgency Left - Fast Money Recap (9/23/08

Sep 23, 2008 • SA Editor Joan Wickham • Comment!
Wall Street Breakfast: Must-Know News

Sep 23, 2008 • SA Editor Eli Hoffmann • 18 Comments
BMY Ups the Ante on ImClone

Sep 23, 2008 • Mike Havrilla • Comment!
Bristol-Myers Raises ImClone Offer to $62

Sep 23, 2008 • Ron Haruni • Comment!
Bristol-Meyers Squibb vs. Imclone: Icahn Stirs Up the Pot

Sep 14, 2008 • Derek Lowe • 3 Comments
Status Report: ImClone Systems - Bristol-Myers Squibb

Sep 14, 2008 • The M & A Researcher • 1 Comment
Ownership of Erbitux Follow-On Is Central to ImClone Takeover

Sep 13, 2008 • EP Vantage • 2 Comments
End The Misery - Fast Money Recap (9/11/08)

Sep 11, 2008 • SA Editor Joan Wickham • Comment!
Wall Street Breakfast: Must-Know News

Sep 11, 2008 • SA Editor Rachael Granby • 10 Comments
ImClone's Icahn Is Holding a Pistol to Bristol

Sep 11, 2008 • Mike Huckman • 4 Comments
When Energy Goes Lower - Fast Money Recap (9/10/08)

Sep 11, 2008 • SA Editor Joan Wickham • 2 Comments
ImClone and the Mystery Bidder

Sep 10, 2008 • Mike Havrilla • 3 Comments
Merger Watch: ImClone Systems - Bristol Myers Squibb

Sep 7, 2008 • The M & A Researcher • 1 Comment

ImClone Systems Inc. (IMCL)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers